(Q38238438)

31 August 2017

Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers (English)

1 reference

31 August 2017

0 references

1 reference

1 reference

Naveed Hasan

1

1 reference

31 August 2017

Rohit Kumar

series ordinal

2

1 reference

31 August 2017

Mani S Kavuru

series ordinal

3

1 reference

31 August 2017

10 August 2014

1 reference

31 August 2017

1 reference

31 August 2017

192

1 reference

31 August 2017

639-648

1 reference

31 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00408-014-9636-z

31 August 2017

0 references

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Current treatment of unresectable lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Revisions in the International System for Staging Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Reduced lung-cancer mortality with low-dose computed tomographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Variations in lung cancer risk among smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

The LLP risk model: an individual risk prediction model for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Targeting of low-dose CT screening according to the risk of lung-cancer death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

The state of molecular biomarkers for the early detection of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Effects of cigarette smoke on the human airway epithelial cell transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

A prediction model for lung cancer diagnosis that integrates genomic and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Development of transcriptomic biomarker signature in human saliva to detect lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Airway PI3K pathway activation is an early and reversible event in lung cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

The value of autofluorescence bronchoscopy combined with white light bronchoscopy compared with white light alone in the diagnosis of intraepithelial neoplasia and invasive lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

A comparison of autofluorescence bronchoscopy and white light bronchoscopy in detection of lung cancer and preneoplastic lesions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Effective detection of bronchial preinvasive lesions by a new autofluorescence imaging bronchovideoscope system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Lung cancer diagnosis from proteomic analysis of preinvasive lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Detection of lung cancer with volatile markers in the breath.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Detection of lung cancer by sensor array analyses of exhaled breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Multiple pathways to tumor immunity and concomitant autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Clinical validation of an autoantibody test for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Evolution of microRNA expression during human bronchial squamous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Diagnostic value of circulating microRNAs for lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

DNA methylation and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

An epigenetic marker panel for detection of lung cancer using cell-free serum DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Blood-based gene expression signatures in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Panel of serum biomarkers for the diagnosis of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Quantification of free circulating DNA as a diagnostic marker in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-014-9636-Z

The natural course of preneoplastic lesions in bronchial epithelium.

21 January 2018

1 reference

12 December 2020

Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer

1 reference

12 December 2020

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

1 reference

12 December 2020

A risk model for prediction of lung cancer

1 reference

12 December 2020

Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy

1 reference

12 December 2020

Prediction of lung cancer using volatile biomarkers in breath

1 reference

12 December 2020

Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period

1 reference

12 December 2020

Angiogenesis and the multistage development of lung cancers.

1 reference

12 December 2020

Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients

1 reference

12 December 2020

Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis

1 reference

12 December 2020

Miss rate of lung cancer on the chest radiograph in clinical practice

1 reference

12 December 2020

Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device

1 reference

12 December 2020

Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients

1 reference

12 December 2020

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

1 reference

12 December 2020

Exhaled breath analysis for lung cancer

1 reference

12 December 2020

Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.

1 reference

12 December 2020

Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?

1 reference

12 December 2020

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

1 reference

12 December 2020

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients

1 reference

12 December 2020

10.1007/S00408-014-9636-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

0 references

1 reference